Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Tests orange peel fermentation for body fat in adults with overweight

Tests a fermented orange peel supplement against placebo in adults who are overweight.

Plain-language title generated from the registry record
Registry title: The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults

Key facts

Where
Taipei, TaiwanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 65 years old?

Source: NCT04496895, who can take part

Where in Taiwan

  • National Taiwan University HospitalTaipei, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
TCI Co., Ltd.
Trial code
NCT04496895
Record updated
29 May 2026
Original description
To assess whether orange peel fermentation has the effect of reducing body fat in adultsRead full original descriptionShow less

The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults

To assess whether orange peel fermentation has the effect of reducing body fat in adults

Inclusion: Adults between the ages of 20 and 65 who are willing to sign the consent form of the subject; For those with BMI ≥ 24 or fatty liver, male body fat ≥ 25%, female body fat ≥ 30%; Those who are not pregnant and are willing to cooperate with contraception during the trial period; No history of cardiovascular disease, history of organ transplantation, history of epilepsy or convulsions, liver and kidney disease, malignant tumor, endocrine disease, mental disease, alcohol or drug abuse, or other major organic diseases (according to medical history).

Exclusion: No person who has received major surgery or bariatric surgery (according to medical history); I have used drugs that affect body fat, waist circumference or significantly increase weight, such as systemic corticosteroids, tricyclic antidepressants, atypical psychiatric drugs, and mood stability in the current or 3 months before participating in the screening Drugs (according to medical history); Pregnant women, people with a history of cardiovascular disease, organ transplantation, epilepsy or convulsions, liver and kidney disease, malignant tumors, endocrine diseases, mental illness, alcohol or drug abuse, and other major organic diseases (according to medical history).

ClinicalTrials.gov NCT04496895